【2024】

Yurie Oka, Jun Matsumoto, Tatsuaki Taked, Naohiro Iwata, Takahiro Niimura, Aya Fukuma Ozaki, Kensuke Bekku, Hirofumi Hamano, Motoo Araki, Keisuke Ishizawa, Yoshito Zamami, Noritaka Ariyoshi. Adverse Events of Nivolumab plus Ipilimumab versus Nivolumab plus Cabozantinib: A Real-World Pharmacovigilance Study. Int J Clin Pharm in press

 

Tatsuaki Takeda, Shiho Sugimoto, Jun Matsumoto, Naohiro Iwata, Akihiko Nakamoto, Aya Fukuma Ozaki, Hirofumi Hamano, Noritaka Ariyoshi, Yoshito Zamami. A comparison between the adverse event profiles of patients receiving palbociclib and abemaciclib: analysis of two real-world databases. Int J Clin Pharm in press

猪田宏美, 武田達明, 西原茂樹, 松本 准, 有吉範高, 座間味義人、パンデミック後の薬学部病院実務実習の変化 、医学教育 in press

【2023】

Matsumoto J, Nishimoto A, Watari S, Ueki H, Shiromizu S, Iwata N, Takeda T, Ushio S, Kajizono M, Fujiyoshi M, Koyama T, Araki M, Wada K, Zamami Y, Nasu Y, Ariyoshi N. Significance of UGT1A6, UGT1A9, and UGT2B7 genetic variants and their mRNA expressions in the clinical outcome of renal cell carcinoma. Mol Cell Biochem478(8): 1779-1790 (2023)

 

Saito Y, Nishi T, Wakabayashi S, Ohno Y, Kitahara H, Ariyoshi N, Kobayashi Y. Derivation of Novel Scoring System Predicting High Platelet Reactivity on Prasugrel in Patients with Coronary Artery Disease. JAtheroscler Thromb29(11):1625-1633 (2023)

Matsumoto J, Iwata N, Watari S, Ushio S, Shiromizu S, Takeda T, Hamano H, Kajizono M, Araki M, Nasu Y, Ariyoshi N, Zamami Y. Adverse Events of Axitinib plus Pembrolizumab Versus Lenvatinib plus Pembrolizumab: A Pharmacovigilance Study in Food and Drug Administration Adverse Event Reporting System. Eur Urol Focus9(1): 141-144 (2023)

Takahiro Niimura, Mitsuhiro Goda, Koji Miyata, Jun Matsumoto, Toshihiko Yoshioka, Hirofumi Hamano, Fuka Aizawa, Kenta Yagi, Yuki Izawa-Ishizawa, Yoshito Zamami, Keisuke Ishizawa. Evaluation of cardiovascular toxicity of the atezolizumab and bevacizumab combination. Front Drug Safe Reg3 (2023)

Satoru Mitsuboshi, Hirofumi Hamano, Yurika Kunki, Takahiro Niimura, Masayuki Chuma, Soichiro Ushio, Tsung-Jen Lin, Jun Matsumoto,Tatsuaki Takeda, Makoto Kajizono, Yoshito Zamami, Keisuke Ishizawa. Proton pump inhibitors and rhabdomyolysis: analysis of two different cross-sectional databases. Annal Pharmacother57(11): 1255-1263 (2023)

【2022】

Saito Y, Nishi T, Wakabayashi S, Ohno Y, Kitahara H, Ariyoshi N, Kobayashi Y. Differential Impact of Clinical and Genetic Factors on High Platelet Reactivity in Coronary Artery Disease Patients Treated with Clopidogrel and Prasugrel. JAtheroscler Thromb29(7):1031-1039 (2022)

 

Matsumoto J, Itano M, Iwata N, Oro M, Kitakaze C, Hirota A, Makino K, Tateno T, Terai R, Kenmotsu H, Date M. Awareness about the establishment of clinical evidence among community pharmacists: A large-scale survey among members of the Okayama Pharmaceutical Association. Yakugaku Zasshi 143(4) 393-404 (2022)

【2021】

Saito Y, Nishi T, Wakabayashi S, Ohno Y, Kitahara H, Ariyoshi N, Kobayashi Y. Differential Impact of Clinical and Genetic Factors on High Platelet Reactivity in Coronary Artery Disease Patients Treated with Clopidogrel and Prasugrel. J Atheroscler Thromb29(7):1031-9 (2021)

Watari S, Araki M, Matsumoto J, Yoshinaga K, Sekito Y, Maruyama Y, Mitsui Y, Sadahira T, Kubota R, Nishimura S, Wada K, Kobayashi Y, Takeuchi H, Tanabe K, Kitagawa M, Morinaga H, Kitamura S, Sugiyama H, Ariyoshi N, Wada J, Watanabe M, Watanabe T, Nasu Y. Blood concentrations of tacrolimus upon conversion from rabeprazole to vonoprazan in renal transplant recipients: correlation with cytochrome P450 gene polymorphisms. Drug Metab Pharmacokinet40:100407 (2021)

Matsumoto J, Kotera Y, Watari S, Takeuchi K, Ueki H, Koyama T, Wada K, Fujiyoshi M, Nasu Y, Ariyoshi N. Relevance of CYP3A5 expression on the clinical outcome of patients with renal cell carcinoma. Anticancer Res41(5):2511-21 (2021)

【2020】

Saito Y, Nishi T, Wakabayashi S, Ohno Y, Kitahara H, Ariyoshi N, Kobayashi Y. Validation of the ABCD-GENE score to identify high platelet reactivity in east Asian patients undergoing percutaneous coronary intervention. Int J Cardiol 327:15-8 (2020)

猪田浩美, 藤吉正哉, 西原茂樹, 松本准, 有吉範高, 千堂年昭, 医療教育 51(5):541-543 (2020)

【2019】

Yamazaki K, Ariyoshi N, Miyauchi H, Ohira G, Kaneya N, Yamamoto K, Arai K, Yamazaki S, Matsubara H, Suzuki T, Ishii I. A randomized controlled, open-label early phase II trial comparing incidence of FOLFIRI.3-induced diarrhea between Hangeshashinto and oral alkalization in Japanese patients with colorectal cancer. J Clin Pharm Ther44(6):946-51 (2019)

San NS, Matsumoto J, Saito Y, Koike M, Sakaue H, Kato Y, Fujiyoshi M, Ariyoshi N, Yamada H. Minor contribution of CYP3A5 to the metabolism of hepatitis C protease inhibitor paritaprevir in vitro. Xenobiotica 49(8), 935-44（2019）

Matsumoto J, Nakamura H, San NS, Sato H, Takezawa M, Kishi R, Kito Y, Sugano J, Izuki M, Yanagisawa N, Ikeda N, Saito Y, Kato Y, Yamada H, Fujiyoshi M, Ariyoshi N. A proposed simple screening method to determine relative contributions of CYP3A4 and CYP3A5 to drug metabolism in vitro. Pers Med Univers8:41-4 (2019)

Ohno Y, Kitahara H, Fujii K, Kohno Y, Ariyoshi N, Nishi T, Fujimoto Y, Kobayashi Y. High residual platelet reactivity after switching from clopidogrel to low-dose prasugrel in Japanese patients with end-stage renal disease on hemodialysis. J Cardiol 73(1):51-7 (2019)

【2018】

Wakabayashi S, Ariyoshi N, Kitahara H, Fujii K, Fujimoto Y, Kobayashi Y. Efficacy of 2.5-mg Prasugrel in Elderly or Low-Body-Weight Patients.Circ J82:2326-31 (2018)

San NS, Matsumoto J, Koike M, Saito Y, Sakaue H, Kato Y, Ariyoshi N, Yamada Y: Determination of sofosbuvir via a high-performance liquid chromatography method using ultraviolet detection. J Int Univ Health Welfare23:130-6（2018）

Maekawa M, Mori M, Fujiyoshi M, Suzuki H, Yanai K, Noda A, Tanaka M, Takasaki S, Kikuchi M, Akasaka K, Kisara S, Matsuura M, Hisamichi K, Sato M, Goto J, Shimada M, Yamaguchi H, Mano N. A Direct Injection LC/ESI-MS/MS Analysis of Urinary Cyclophosphamide as an Anticancer Drug for Monitoring Occupational Exposure. Chromatography39:41-7 (2018)

Honzumi S, Takeuchi M, Kurihara M, Fujiyoshi M, Uchida M, Watanabe K, Suzuki T, Ishii I. The effect of cholesterol overload on mouse kidney and kidney-derived cells.Ren Fail 40:43-50 (2018)

Wakabayashi S, Kitahara H, Nishi T, Sugimoto K, Nakayama T, Fujimoto Y, Ariyoshi N, Kobayashi Y. Platelet inhibition after loading dose of prasugrel in patients with ST-elevation and non-ST-elevation acute coronary syndrome. Cardiovasc Interv Ther33:239-46 (2018)

【2017】

Nishi T, Ariyoshi N, Nakayama T, Fujimoto Y, Sugimoto K, Wakabayashi S, Hanaoka H, Kobayashi Y. Impact of Chronic Kidney Disease on Platelet Inhibition of Clopidogrel and Prasugrel in Japanese Patients.J. Cardiol69:752-5 (2017)